Navigation Links
ABSTRAL® (fentanyl) Sublingual Tablets CII, First-in-class, Sublingual, Immediate Release Opioid for Managing Breakthrough Cancer Pain, Now Available in the U.S.
Date:4/4/2011

e analgesic that disintegrates quickly under the tongue. It offers an alternative therapeutic choice to patients and clinicians with a simple, patient-friendly and predictable way of delivering fentanyl transmucosally, while retaining the individualized dose titration aspects required for optimal treatment of breakthrough pain.

ABSTRAL REMS Program

ABSTRAL is the first and only sublingual, transmucosal, immediate release fentanyl product to be available through a class-wide Risk Evaluation and Mitigation Strategy (REMS) program mandated and approved by the F.D.A., which requires health care professionals and pharmacies that prescribe or distribute ABSTRAL to patients in the community setting to enroll in the program. Starting in April, ABSTRAL will be available in those chain and independent pharmacies that have enrolled in the ABSTRAL REMS program.

"The improper use of opioid medications is a serious issue with potentially devastating consequences for patients and the broader community. Through the ABSTRAL REMS program, ProStrakan has committed to providing necessary education around the benefits and risks of opioid pain management," said Abid Karim, President of Global Commercial Operations. "ProStrakan strives to provide access to safe and effective treatment options to address the unmet needs of cancer patients and the healthcare community."

The goal of the ABSTRAL REMS program is to provide effective access to ABSTRAL while mitigating the risk of misuse, abuse, addiction, overdose and serious complications due to medication errors by:

  • Prescribing and dispensing ABSTRAL only to appropriate patients, which includes use only in opioid-tolerant patients.
  • Preventing inappropriate conversion between fentanyl products.
  • Preventing accidental exposure to children and others for whom it was not prescribed.
  • Educating prescribers, pharmacists, and patients on the potentia
    '/>"/>

SOURCE ProStrakan Group plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. MonoSol Rx, LLC Announces Suboxone Sublingual Film Achieves 25% Share of Total U.S. Suboxone Market Volume at Year-End 2010
2. INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
3. Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies
4. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
5. Qualitest Receives FDA Approval for Toresmide Tablets (Generic Demadex®) 5 mg, 10 mg, 20 mg, 100 mg, for the Treatment of Edema Associated with Congestive Heart Failure, Renal Disease, or Hepatic Disease
6. Actavis Receives Approval of Valacyclovir Hydrochloride Tablets in the U.S.
7. Florida Pain Clinic Society: 3.7 Billion Oxycodone Tablets Dispensed in U.S.
8. FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
9. Mylan Launches First Generic Version of Vfend® Tablets
10. Actavis Receives Approval of Pantoprazole Sodium Delayed-Release Tablets, USP in the U.S.
11. Qualitest Pharmaceuticals Issues Voluntary, Nationwide Recall of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg / 500 mg, NDC 0603-3888-20, 60 Count, Lot Numbers T150G10B, T120J10E and T023M10A and Phenobarbital Tablets, USP 32.4 mg, ND
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014  Nektar Therapeutics (Nasdaq: NKTR ) ... June 30, 2014 on Thursday, July 31, 2014, after the ... and chief executive officer, will host a conference call to ... p.m. Pacific Time (PT). The press release ... be accessed through a link that is posted on the ...
(Date:7/22/2014)... , July 22, 2014  Edwards Lifesciences Corporation ... the science of heart valves and hemodynamic monitoring, announced ... today served as an expert panelist at the ... Subcommittee on Health to discuss medical device innovation at ... to Ongoing Evidence Development and Communication." "Edwards ...
(Date:7/22/2014)... July 22, 2014  Jazz Pharmaceuticals plc (Nasdaq: ... its 2014 second quarter financial results on Tuesday, August ... Company management will host a live audio webcast immediately ... to provide a business and financial update and discuss ... may access the live audio webcast via the Investors ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2
(Date:7/23/2014)... On July 21, 2014, My Positive Perspective host ... for an episode that spoke about the group Darkness to ... to talk some about the formation of the group, Tracey ... was started right here in Charleston, originally it was called ... survivors of sexual abuse. Their purpose has shifted to educating ...
(Date:7/23/2014)... As the push for marriage ... understanding the unique circumstances and special needs of ... To help lesbians pursue parenthood with knowledge and ... hosting a free, educational event about pregnancy and ... lesbian couples, not knowing legal and medical options ...
(Date:7/23/2014)... ANTONIO (July 22, 2014) Mouse models of human ... dramatic tumor shrinkage without damage to surrounding tissues, researchers ... at The University of Texas Health Science Center at ... intellectual property on results of the study, which is ... Late diagnosis, low survival , Oral squamous ...
(Date:7/23/2014)... Follow us on LinkedIn ... proportions in both developed and developing countries alike. Rising ... growing preference for processed food, and sedentary lifestyles present ... regarded a disease by itself, obesity is known to ... diabetes, hypertension, cardiovascular risks as well as cancer. The ...
(Date:7/23/2014)... 23, 2014 The Case Management Society of ... Day on the Hill, a one-day event that will bring ... awareness to Congress on the importance of case management to ... on September 10, 2014, at the U.S. Capitol Visitors Center ... Hill provides participants with the opportunity to play a direct ...
Breaking Medicine News(10 mins):Health News:My Positive Perspective Airs Episode to Raise Attention to the Group Darkness to Light 2Health News:Gay Women’s Gathering ™ in Chicago: An Evening about Lesbian Pregnancy 2Health News:Gay Women’s Gathering ™ in Chicago: An Evening about Lesbian Pregnancy 3Health News:Gay Women’s Gathering ™ in Chicago: An Evening about Lesbian Pregnancy 4Health News:Anti-pain agent shrinks oral cancers, leaves healthy tissues alone 2Health News:Surging Obesity Rates Drives Demand for Bariatric (Obesity) Surgical Devices, According to New Report by Global Industry Analysts, Inc. 2Health News:Surging Obesity Rates Drives Demand for Bariatric (Obesity) Surgical Devices, According to New Report by Global Industry Analysts, Inc. 3Health News:Surging Obesity Rates Drives Demand for Bariatric (Obesity) Surgical Devices, According to New Report by Global Industry Analysts, Inc. 4Health News:CMSA Launches Registration for the 2014 Day on the Hill 2
... on high alert Wednesday following the first confirmed outbreak of ... thousands of poultry were slaughtered in the Mekong// Delta. ... southern Ca Mau and Bac Lieu provinces, after tests on ... H5N1 strain of avian influenza., ,'We have begun to ...
... conducted by a US research company has highlighted the ... formidable health// problem facing society and their children today. ... 800 adults, found that nearly 27% named 'obesity', as ... insurance followed next with 16% strongly advocating action, ...
... North Carolina at Chapel Hill suggested that low LDL ... ,LDL stands for low density lipoprotein; the low ... Previously associations have been made between LDL and cardiovascular ... Parkinson's disease have a lower occurrence of heart attack ...
... the University of Texas M. D. Anderson Cancer Center suggest ... span of 40 years reduced the tumor growth in the// ... ,The Journal of the National Cancer Institute issued ... drug cromolyn is three times more effective than just the ...
... holding her husband’s hand, says a study. This is indeed ... of marriage// is losing ground. ,A new study ... Virginia, finds that women in a threatening situation show signs ... has been observed in brain scans. ,The researchers, ...
... Andy Kerr will receive Christmas cards from active members ... poor quality of treatment// offered to Chronic Obstructive Pulmonary ... charity suggests that clinical standards be set, to ensure ... ,COPD or Chronic Obstructive Pulmonary Disease is a term ...
Cached Medicine News:Health News:Low LDL Levels Lead to Parkinson's Disease 2Health News:Anti Allergy Drugs Reduce Tumor Growth 2Health News:Anti Allergy Drugs Reduce Tumor Growth 3
Plus cylinders only trial lens set....
This is a reduced form of the 100 Hue test and is obviously quicker to administer. It provides extensive chromatic sensitivity and gives a quantitative score. Kit includes 100 score pads....
... The L'Anthony 15 disc test (P/N ... for copying, and comprehensive instructions. P/N LD15C ... supply of finger tip covers for the ... and accuracy of the color discs). Beware ...
Opti-One multi-purpose solution with citrate protein removal and advanced surfactant combination....
Medicine Products: